A detailed history of Pds Planning, Inc transactions in Boston Scientific Corp stock. As of the latest transaction made, Pds Planning, Inc holds 7,361 shares of BSX stock, worth $654,760. This represents 0.06% of its overall portfolio holdings.

Number of Shares
7,361
Previous 7,169 2.68%
Holding current value
$654,760
Previous $552,000 11.59%
% of portfolio
0.06%
Previous 0.06%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$72.96 - $84.0 $14,008 - $16,128
192 Added 2.68%
7,361 $616,000
Q2 2024

Aug 07, 2024

BUY
$67.33 - $77.71 $113,787 - $131,329
1,690 Added 30.85%
7,169 $552,000
Q1 2024

May 01, 2024

BUY
$57.6 - $68.62 $29,664 - $35,339
515 Added 10.37%
5,479 $375,000
Q4 2023

Feb 01, 2024

BUY
$48.64 - $57.81 $24,125 - $28,673
496 Added 11.1%
4,964 $286,000
Q3 2023

Oct 20, 2023

BUY
$50.19 - $54.68 $19,022 - $20,723
379 Added 9.27%
4,468 $235,000
Q2 2023

Jul 20, 2023

BUY
$49.72 - $54.64 $203,305 - $223,422
4,089 New
4,089 $221,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $127B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Pds Planning, Inc Portfolio

Follow Pds Planning, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pds Planning, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Pds Planning, Inc with notifications on news.